SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
EssilorLuxottica S.A. (ESLOF) trades at a trailing P/E of 48.1, forward P/E of 32.2. Trailing earnings yield is 2.08%, forward earnings yield 3.10%. PEG 0.65 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 48.1).
- Forward P/E 32.2 (down from trailing 48.1) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.65 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 2.08% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 3.10% as earnings recover.
Overall SharesGrow Score: 55/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ESLOF
Valuation Multiples
P/E (TTM)48.1
Forward P/E32.2
PEG Ratio0.65
Forward PEG0.65
P/B Ratio0.00
P/S Ratio3.90
EV/EBITDA0.0
Per Share Data
EPS (TTM)$4.98
Forward EPS (Est.)$7.43
Book Value / Share$0.00
Revenue / Share$61.29
FCF / Share$0.00
Yields & Fair Value
Earnings Yield2.08%
Forward Earnings Yield3.10%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$3.71 |
$7.12B |
$813M |
11.4% |
| 2017 |
$3.58 |
$7.49B |
$789M |
10.5% |
| 2018 |
$4.07 |
$10.8B |
$1.08B |
10% |
| 2019 |
$2.44 |
$17.39B |
$1.08B |
6.2% |
| 2020 |
$0.19 |
$14.43B |
$85M |
0.6% |
| 2021 |
$3.25 |
$19.82B |
$1.45B |
7.3% |
| 2022 |
$4.83 |
$24.49B |
$2.15B |
8.8% |
| 2023 |
$5.08 |
$25.4B |
$2.29B |
9% |
| 2024 |
$5.13 |
$26.51B |
$2.36B |
8.9% |
| 2025 |
$4.98 |
$28.48B |
$2.31B |
8.1% |
